Every client will require a specific dose of Semaglutide, but it is typically administered weekly
However, chronic GH treatment carries substantial risks, including glucose intolerance, insulin resistance, diabetes, cancer, and cardiovascular complications
It is strictly designated for laboratory research only and is not approved for human or animal administration
Additionally, its fat loss benefits could indirectly alleviate joint stress by reducing excess weight
It works at the cellular level within the fat tissue itself
However, its important to note that there is no FDA-approved version of this medication, so no clinical trial data exists to substantiate the risk profile